Comprehensive Methylation Profile of CSF cf DNA Revealed Pathogenesis and Diagnostic Markers for Early-Onset Parkinson’s Disease

References

• Ascherio A , SchwarzschildMA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet. Neurol.15(12), 1257–1272 (2016).
   PubMed Web of Science ®Google Scholar
• Lim SY , TanAH , Ahmad-AnnuarAet al. Parkinson’s disease in the western Pacific region. Lancet Neurol.18(9), 865–879 (2019).
   PubMed Web of Science ®Google Scholar
• Lunati A , LesageS , BriceA. The genetic landscape of Parkinson’s disease. Rev. Neurol (Paris).174(9), 628–643 (2018).
   PubMed Web of Science ®Google Scholar
• Goldman SM . Environmental toxins and Parkinson’s disease. Annu. Rev. Pharmacol. Toxicol.54, 141–164 (2014).
   PubMed Web of Science ®Google Scholar
• Trist BG , HareDJ , DoubleKL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell.18(6), e13031 (2019).
   PubMed Web of Science ®Google Scholar
• Camerucci E , StangCD , HajebMet al. Early-onset Parkinsonism and early-onset Parkinson’s disease: a population-based study (2010–2015). J. Parkinsons Dis.11(3), 1197–1207 (2021).
   PubMedGoogle Scholar
• Ferguson LW , RajputAH , RajputA. Early-onset vs. late-onset Parkinson’s disease: a clinical-pathological study. Can. J. Neurol. Sci.43(1), 113–119 (2016).
   PubMed Web of Science ®Google Scholar
• Schrag A , SchottJM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol.5(4), 355–363 (2006).
   PubMed Web of Science ®Google Scholar
• Friedman A . Old-onset Parkinson’s disease compared with young-onset disease: clinical differences and similarities. Acta Neurol. Scand.89(4), 258–261 (1994).
   PubMed Web of Science ®Google Scholar
• Gomez Arevalo G , JorgeR , GarciaS , ScipioniO , GershanikO. Clinical and pharmacological differences in early- versus late-onset Parkinson’s disease. Mov. Disord.12(3), 277–284 (1997).
   PubMed Web of Science ®Google Scholar
• Gibb WR , LeesAJ. A comparison of clinical and pathological features of young- and old-onset Parkinson’s disease. Neurology38(9), 1402–1406 (1988).
   PubMed Web of Science ®Google Scholar
• Corti O , LesageS , BriceA. What genetics tells us about the causes and mechanisms of Parkinson’s disease. Physiol Rev.91(4), 1161–1218 (2011).
   PubMed Web of Science ®Google Scholar
• Masliah E , RockensteinE , VeinbergsIet al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science287(5456), 1265–1269 (2000).
   PubMed Web of Science ®Google Scholar
• Cheon SM , ChanL , ChanDK , KimJW. Genetics of Parkinson’s disease: a clinical perspective. J. Mov. Disord.5(2), 33–41 (2012).
   PubMedGoogle Scholar
• Coppedè F . Genetics and epigenetics of Parkinson’s disease. Scientific World Journal.2012, 489830 (2012).
   Google Scholar
• Miranda-Morales E , MeierK , Sandoval-CarrilloA , Salas-PachecoJ , Vázquez-CárdenasP , Arias-CarriónO. Implications of DNA methylation in Parkinson’s disease. Front. Mol. Neurosci.10, 225 (2017).
   PubMed Web of Science ®Google Scholar
• Nalls MA , PankratzN , LillCMet al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet.46(9), 989–993 (2014).
   PubMed Web of Science ®Google Scholar
• Wüllner U , KautO , deBoniL , PistonD , SchmittI. DNA methylation in Parkinson’s disease. J. Neurochem.139(Suppl. 1), 108–120 (2016).
   PubMedGoogle Scholar
• Young JI , SivasankaranSK , WangLet al. Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease. Neurol. Genet.5(4), e342 (2019).
   PubMedGoogle Scholar
• Labbé C , Lorenzo-BetancorO , RossOA. Epigenetic regulation in Parkinson’s disease. Acta. Neuropathol.132(4), 515–530 (2016).
   PubMed Web of Science ®Google Scholar
• Gansauge MT , GerberT , GlockeIet al. Single-stranded DNA library preparation from highly degraded DNA using T4 DNA ligase. Nucleic Acids Res.45(10), e79 (2017).
   PubMed Web of Science ®Google Scholar
• Wang Q , GuL , AdeyAet al. Tagmentation-based whole-genome bisulfite sequencing. Nat. Protoc.8(10), 2022–2032 (2013).
   PubMed Web of Science ®Google Scholar
• Chen S , ZhouY , ChenY , GuJ. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics34(17), i884–i890 (2018).
   PubMed Web of Science ®Google Scholar
• Wöste M , LeitãoE , LaurentinoS , HorsthemkeB , RahmannS , SchröderC. Wg-blimp: an end-to-end analysis pipeline for whole genome bisulfite sequencing data. BMC Bioinformatics21(1), 169 (2020).
   PubMed Web of Science ®Google Scholar
• Ehrlich M . DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics14(12), 1141–1163 (2019).
   PubMed Web of Science ®Google Scholar
• Law PP , HollandML. DNA methylation at the crossroads of gene and environment interactions. Essays Biochem.63(6), 717–726 (2019).
   PubMed Web of Science ®Google Scholar
• Sawaki K , KandaM , KoderaY. Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer. Expert Rev. Gastroenterol. Hepatol.12(7), 657–670 (2018).
   PubMed Web of Science ®Google Scholar
• Reece M , SalujaH , HollingtonPet al. The use of circulating tumor DNA to monitor and predict response to treatment in colorectal cancer. Front. Genet.10, 1118 (2019).
   PubMed Web of Science ®Google Scholar
• Shemer R , MagenheimJ , DorY. Digital droplet PCR for monitoring tissue-specific cell death using DNA methylation patterns of circulating cell-free DNA. Curr. Protoc. Mol. Biol.127(1), e90 (2019).
   PubMedGoogle Scholar
• Chen X , YuC , GuoMet al. Down-regulation of m6A mRNA methylation is involved in dopaminergic neuronal death. ACS Chem. Neurosci.10(5), 2355–2363 (2019).
   PubMed Web of Science ®Google Scholar
• Farinelli P , PereraA , Arango-GonzalezBet al. DNA methylation and differential gene regulation in photoreceptor cell death. Cell Death Dis.5(12), e1558 (2014).
   PubMedGoogle Scholar
• Wahlin KJ , EnkeRA , FullerJA , KalesnykasG , ZackDJ , MerbsSL. Epigenetics and cell death: DNA hypermethylation in programmed retinal cell death. PLoS ONE8(11), e79140 (2013).
   PubMed Web of Science ®Google Scholar
• Greenberg MVC , Bourc’hisD. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol.20(10), 590–607 (2019).
   PubMed Web of Science ®Google Scholar
• Dauer W , PrzedborskiS. Parkinson’s disease: mechanisms and models. Neuron39(6), 889–909 (2003).
   PubMed Web of Science ®Google Scholar
• Moore LD , LeT , FanG. DNA methylation and its basic function. Neuropsychopharmacology38(1), 23–38 (2013).
   PubMed Web of Science ®Google Scholar
• Hwang JY , AromolaranKA , ZukinRS. The emerging field of epigenetics in neurodegeneration and neuroprotection [published correction appears in Nat Rev Neurosci. 2018 Dec; 19(12): 771]. Nat. Rev. Neurosci.18(6), 347–361 (2017).
   PubMed Web of Science ®Google Scholar
• Nguyen M , WongYC , YsselsteinD , SeverinoA , KraincD. Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson’s disease. Trends. Neurosci.42(2), 140–149 (2019).
   PubMed Web of Science ®Google Scholar
• Mallet N , DelgadoL , ChazalonM , MiguelezC , BaufretonJ. Cellular and synaptic dysfunctions in Parkinson’s disease: stepping out of the striatum. Cells8(9), 1005 (2019).
   PubMed Web of Science ®Google Scholar
• Bagetta V , GhiglieriV , SgobioC , CalabresiP , PicconiB. Synaptic dysfunction in Parkinson’s disease. Biochem. Soc. Trans.38(2), 493–497 (2010).
   PubMedGoogle Scholar
• Picconi B , PiccoliG , CalabresiP. Synaptic dysfunction in Parkinson’s disease. Adv. Exp. Med. Biol.970, 553–572 (2012).
   PubMed Web of Science ®Google Scholar
• Kumar P , KumarD , JhaSK , JhaNK , AmbastaRK. Ion channels in neurological disorders. Adv. Protein Chem. Struct. Biol.103, 97–136 (2016).
   PubMed Web of Science ®Google Scholar
• De Virgilio A , GrecoA , FabbriniGet al. Parkinson’s disease: autoimmunity and neuroinflammation. Autoimmun. Rev.15(10), 1005–1011 (2016).
   PubMed Web of Science ®Google Scholar
• Gelders G , BaekelandtV , Vander Perren A. Linking neuroinflammation and neurodegeneration in Parkinson’s disease. J. Immunol. Res.2018, 4784268 (2018).
   PubMed Web of Science ®Google Scholar
• Hirsch EC , HunotS. Neuroinflammation in Parkinson’s disease: a target for neuroprotection?Lancet Neurol.8(4), 382–397 (2009).
   PubMed Web of Science ®Google Scholar
• Tansey MG , Romero-RamosM. Immune system responses in Parkinson’s disease: early and dynamic. Eur. J. Neurosci.49(3), 364–383 (2019).
   PubMed Web of Science ®Google Scholar
• Earls RH , LeeJK. The role of natural killer cells in Parkinson’s disease. Exp. Mol. Med.52(9), 1517–1525 (2020).
   PubMed Web of Science ®Google Scholar
• Bettiol SS , RoseTC , HughesCJ , SmithLA. Alcohol consumption and Parkinson’s disease risk: a review of recent findings. J. Parkinsons Dis.5(3), 425–442 (2015).
   PubMedGoogle Scholar
• Wegrzyk J , ArmandS , ChiuvéSC , BurkhardPR , AllaliG. Education level affects dual-task gait after deep brain stimulation in Parkinson’s disease. Parkinsonism Relat. Disord.68, 65–68 (2019).
   PubMed Web of Science ®Google Scholar
• Chuang YH , LuAT , PaulKCet al. Longitudinal epigenome-wide methylation study of cognitive decline and motor progression in Parkinson’s disease. J. Parkinsons Dis.9(2), 389–400 (2019).
   PubMedGoogle Scholar
• Eryilmaz IE , CecenerG , ErerSet al. Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions. Neurol. Res.39(11), 965–972 (2017).
   PubMed Web of Science ®Google Scholar
• Nalls MA , McLeanCY , RickJet al. Diagnosis of Parkinson’s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol.14(10), 1002–1009 (2015).
   PubMed Web of Science ®Google Scholar
• Dickson DW , BraakH , DudaJEet al. Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria [published correction appears in Lancet Neurol. Lancet. Neurol.8(12), 1150–1157 (2009).
   PubMed Web of Science ®Google Scholar
• Erer S , EgeliU , ZarifogluMet al. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson’s patients and genotype-phenotype correlations. Clin. Neurol. Neurosurg.148, 147–153 (2016).
   PubMed Web of Science ®Google Scholar
• Matsumoto L , TakumaH , TamaokaAet al. CpG demethylation enhances alpha-synuclein expression and affects the pathogenesis of Parkinson’s disease. PLoS ONE5(11), e15522 (2010).
   PubMed Web of Science ®Google Scholar
• Tan YY , WuL , ZhaoZBet al. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson’s disease patients. Parkinsonism Relat. Disord.20(3), 308–313 (2014).
   PubMed Web of Science ®Google Scholar
• Richter J , AppenzellerS , AmmerpohlOet al. No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson’s disease patients. Mov. Disord.27(4), 590–591 (2012).
   PubMed Web of Science ®Google Scholar
• Pihlstrøm L , BergeV , RengmarkA , ToftM. Parkinson’s disease correlates with promoter methylation in the α-synuclein gene. Mov. Disord.30(4), 577–580 (2015).
   PubMed Web of Science ®Google Scholar
• de Boni L , TierlingS , RoeberS , WalterJ , GieseA , KretzschmarHA. Next-generation sequencing reveals regional differences of the α-synuclein methylation state independent of Lewy body disease. Neuromolecular Med.13(4), 310–320 (2011).
   PubMed Web of Science ®Google Scholar
• Ai SX , XuQ , HuYCet al. Hypomethylation of SNCA in blood of patients with sporadic Parkinson’s disease. J. Neurol. Sci.337(1–2), 123–128 (2014).
   PubMed Web of Science ®Google Scholar
• De Mena L , CardoLF , CotoE , AlvarezV , CotoE. No differential DNA methylation of PARK2 in brain of Parkinson’s disease patients and healthy controls. Mov. Disord.28(14), 2032–2033 (2013).
   PubMed Web of Science ®Google Scholar
• Cai M , TianJ , ZhaoGH , LuoW , ZhangBR. Study of methylation levels of parkin gene promoter in Parkinson’s disease patients. Int. J. Neurosci.121(9), 497–502 (2011).
   PubMed Web of Science ®Google Scholar
• Masliah E , DumaopW , GalaskoD , DesplatsP. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics8(10), 1030–1038 (2013).
   PubMed Web of Science ®Google Scholar
• Calligaris R , BanicaM , RoncagliaPet al. Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients. BMC Genomics.16, 876 (2015).
   PubMed Web of Science ®Google Scholar